<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03058679</url>
  </required_header>
  <id_info>
    <org_study_id>825907</org_study_id>
    <nct_id>NCT03058679</nct_id>
  </id_info>
  <brief_title>Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission of Crohn's Disease</brief_title>
  <acronym>DINE-CD</acronym>
  <official_title>Open Label, Randomized, Multicenter, Comparative Effectiveness Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission in Patients With Crohn's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Crohn's and Colitis Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This protocol is designed to compare the effectiveness of two dietary interventions for
      patients with Crohn's disease (CD): the Specific Carbohydrate Diet (SCD) and a Mediterranean
      style diet (MSD) that has been demonstrated to have numerous other health benefits. The two
      diets will be compared in terms of their ability to resolve both the symptoms and bowel
      inflammation that characterize this debilitating disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 29, 2017</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Symptomatic remission</measure>
    <time_frame>6 weeks</time_frame>
    <description>Assessed by Short Crohn's Disease Activity Index (sCDAI) - diarrhea, abdominal pain and general well being</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduction in bowel inflammation</measure>
    <time_frame>6 weeks</time_frame>
    <description>Calprotectin &lt;250 mcg/gm and &gt;50% reduction from baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical remission</measure>
    <time_frame>6 weeks</time_frame>
    <description>Assessed by the Harvey Bradshaw Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in systemic inflammation</measure>
    <time_frame>6 weeks</time_frame>
    <description>hsCRP &lt; 5mg/L &gt;50% reduction from baseline</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">194</enrollment>
  <condition>Crohn Disease</condition>
  <arm_group>
    <arm_group_label>Specific Carbohydrate Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Mediterranean Style Diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diet</intervention_name>
    <description>food for the diet will be provided to the participants for 6 weeks</description>
    <arm_group_label>Specific Carbohydrate Diet</arm_group_label>
    <arm_group_label>Mediterranean Style Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ≥18

          2. Documented diagnosis of Crohn's disease

          3. sCDAI score &gt;175

          4. Active inflammation documented by a FCP concentration &gt;250ug/g or high sensitivity
             C-reactive protein (hs-CRP)&gt;5 mg/L measured at screening.

          5. Access to a computer with internet and the ability to complete daily online surveys

          6. Capable of providing consent to participate

          7. Able to receive weekly food shipments delivered every Friday for 6 weeks

        Exclusion Criteria:

          1. Pregnancy

          2. sCDAI &gt;400

          3. Hospitalized patients

          4. Anticipated need for surgery within 6 weeks of randomization

          5. Use of the Specific Carbohydrate Diet within 4 weeks of screening

          6. Start or change dose of thiopurines (azathioprine and 6-MP), methotrexate,
             natalizumab, or vedolizumab within 12 weeks prior to randomization

          7. Start or change dose of anti-TNF agents (including infliximab, adalimumab,
             certolizumab pegol, golimumab) or ustekinumab within 8 weeks prior to randomization

          8. Start or change dose of corticosteroids within 1 week of screening or a dose &gt;20mg/day
             prednisone or equivalent*

          9. Known symptomatic intestinal stricture.

         10. Presence of an ostomy

         11. Baseline stool frequency &gt;4 bowel movements/day when well

         12. BMI &lt;16

         13. BMI ≥40

         14. Celiac disease

         15. Documented C difficile colitis within four weeks of screening

         16. Diabetes Mellitus requiring medication

         17. Albumin&lt;2.0mg/dl, within 4 weeks of screening (if tested as part of routine clinical
             care)

         18. Known allergy to nuts

         19. Other conditions that would be a contraindication to any of the study diets or
             preclude the participant from completing the study.

         20. Currently participating in another clinical trial of a drug to treat IBD or a dietary
             therapy for any indication.

               -  Patients may continue these medications at stable dose for the first six weeks
                  and budesonide may be used at any dose. After the 6th week in the study, patients
                  may taper their steroid dose. The study will provide a recommended taper
                  schedule.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James D Lewis, MD, MSCE</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adam M Hawkins</last_name>
    <phone>215-746-4218</phone>
    <email>ahawkeye@mail.med.upenn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lisa C Nessel, MSS, MLSP</last_name>
    <phone>215-573-6003</phone>
    <email>nessel@mail.med.upenn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UCSF Colitis and Crohn's Disease Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Berman</last_name>
      <phone>415-514-8947</phone>
      <email>Michael.Berman@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Uma Mahadevan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Atlanta Gastroenterology</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Wolf</last_name>
      <phone>404-257-9000</phone>
      <phone_ext>2142</phone_ext>
      <email>mailto:christine.wolf@atlantagastro.com</email>
    </contact>
    <investigator>
      <last_name>Douglas Wolf, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NorthShore University HealthSystem</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Obaid Ansari</last_name>
      <phone>847-570-3708</phone>
      <email>OAnsari@northshore.org</email>
    </contact>
    <investigator>
      <last_name>Eugene Yen,, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Kim</last_name>
      <phone>312-926-5250</phone>
      <email>lisa.kim@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Stephen B Hanauer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University Health University Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debbie Drenzyk</last_name>
      <phone>317-948-9212</phone>
      <email>robinsd@iu.edu</email>
    </contact>
    <investigator>
      <last_name>Monika Fischer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzanne Mann, LPN</last_name>
      <phone>502-852-1919</phone>
      <email>mailto:susie.mann@louisville.edu</email>
    </contact>
    <investigator>
      <last_name>Gerald W Dryden, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thelma Harrington</last_name>
      <phone>410-706-5943</phone>
      <email>THarrington@som.umaryland.edu</email>
    </contact>
    <investigator>
      <last_name>Sandra Quezada, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline Rourke</last_name>
      <phone>617-919-4592</phone>
      <email>Caroline.Rourke@childrens.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Bridget Hron, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Brunette</last_name>
      <phone>734-647-4548</phone>
      <email>mailto:ksauder@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Peter D Higgins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Research Institute of Michigan</name>
      <address>
        <city>Chesterfield</city>
        <state>Michigan</state>
        <zip>48047</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aaron Ryder</last_name>
      <phone>586-598-3329</phone>
      <email>aryder@researchmi.com</email>
    </contact>
    <investigator>
      <last_name>Ronald P Fogel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Minnesota Gastroenterology, P.A</name>
      <address>
        <city>Plymouth</city>
        <state>Minnesota</state>
        <zip>55446</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irena Davies</last_name>
      <phone>612-870-5587</phone>
      <email>Irena.Davies@mngastro.com</email>
    </contact>
    <investigator>
      <last_name>Robert McCabe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic - Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brenda Becker</last_name>
      <phone>507-284-5486</phone>
      <email>becker.brenda1@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Sunanda Kane, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Penny Doughty</last_name>
      <phone>603-653-6048</phone>
      <email>Penny.J.Doughty@hitchcock.org</email>
    </contact>
    <investigator>
      <last_name>L. Campbell Levy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory Pappas</last_name>
      <phone>646-501-7984</phone>
      <email>Gregory.Pappas@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>David Hudesman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Weill Cornell - NewYork Presbyterian</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fatiha Chabouni</last_name>
      <phone>212-746-5109</phone>
      <email>fac2005@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Ellen J Scherl, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Nolan</last_name>
      <phone>212-824-7699</phone>
      <email>amy.nolan@mssm.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sari Feldman</last_name>
      <phone>212-824-7669</phone>
      <email>sari.feldman@mssm.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Benjamin Cohen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lenox Hill Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10075</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Durbin, MPH</last_name>
      <phone>212-434-3941</phone>
      <email>ldurbin@northwell.edu</email>
    </contact>
    <investigator>
      <last_name>Arun Swaminath, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Jackson, MPA</last_name>
      <phone>919-843-9071</phone>
      <email>susan_jackson@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Hans Herfarth, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alisha Davis</last_name>
      <phone>336-713-7319</phone>
      <email>atdavis@wakehealth.edu</email>
    </contact>
    <investigator>
      <last_name>Patrick Green, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Missy Randolph</last_name>
      <phone>513-558-5529</phone>
      <email>RANDOLLJ@ucmail.uc.edu</email>
    </contact>
    <investigator>
      <last_name>Bruce Yacyshyn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Cleveland Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynn Richardson</last_name>
      <phone>216-844-7214</phone>
      <email>Lynn.Richardson@UHhospitals.org</email>
    </contact>
    <investigator>
      <last_name>Jeffry Katz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam Hawkins</last_name>
      <phone>215-746-4218</phone>
      <email>ahawkeye@pennmedicine.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>James D Lewis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Goldby-Reffner, RN</last_name>
      <phone>412-648-9173</phone>
      <email>mailto:goldbyreffnerka@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Marc Schwartz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Laundry</last_name>
      <phone>615-322-4573</phone>
      <email>erin.vozar@Vanderbilt.edu</email>
    </contact>
    <investigator>
      <last_name>Sara Horst, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Will</last_name>
      <phone>801-587-9060</phone>
      <email>Julie.will@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Ann Flynn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Mason Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angie Neal</last_name>
      <phone>206-341-1413</phone>
      <email>Angie.Neal@virginiamason.org</email>
    </contact>
    <investigator>
      <last_name>Michael Chiorean, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin-Madison</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53706</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lindsay Luedke</last_name>
      <phone>608-262-5404</phone>
      <email>leluedke@medicine.wisc.edu</email>
    </contact>
    <investigator>
      <last_name>Sumona Saha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2017</study_first_submitted>
  <study_first_submitted_qc>February 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2017</study_first_posted>
  <last_update_submitted>May 17, 2018</last_update_submitted>
  <last_update_submitted_qc>May 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diet</keyword>
  <keyword>specific carbohydrate diet</keyword>
  <keyword>Mediterranean style diet</keyword>
  <keyword>randomized controlled trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

